期刊文献+

细胞色素P450酶4F2基因多态性对华法林剂量影响的研究 被引量:13

Association of CYP4F2 Gene Polymorphism with Warfarin Dose
下载PDF
导出
摘要 目的:探讨中国苏南地区心脏机械瓣膜置换术后汉族人群细胞色素P450酶4F2(CYP4F2)基因rs2108622多态性对华法林剂量的影响,为以后利用基因多态性指导临床合理用药提供进一步理论依据。方法:采用碱基淬灭探针技术,检测197名心脏机械瓣膜置换术后患者的CYP4F2 rs2108622的基因型,分析与华法林剂量的相关性及影响。结果:CYP4F2 rs2108622基因多态性检测有115例CC型纯合子,73例CT型杂合子,9例TT型突变纯合子;等位基因频率为C 76.9%,T 23.1%;CC型患者华法林的平均稳定剂量为(2.51±0.82)mg.d-1,CT型为(2.74±0.96)mg.d-1,TT型为(3.20±1.22)mg.d-1,采用方差分析方法得到各组间华法林剂量差异P值小于0.05,有显著性差异。结论:在苏南地区心脏机械瓣膜置换术后汉族人群中,CYP4F2 rs2108622基因多态性与华法林剂量相关性有显著性差异,对华法林剂量有影响。 Objective:To investigate the association of CYP4F2 rs2108622 polymorphism with warfarin maintenance dose in the Han population of the south of Jiangsu province of Chinese.Methods:The single nucleotide polymorphism was detected by using a base-quenched probe technique.CYP4F2 rs2108622 polymorphisms were analyzed in 197 patients with mechanical heart valve replacement.Results:The genotypes of CYP4F2 rs2108622 showed that 115 patients were homozygous CC,73 were heterozygous CT,and 9 were homozygous TT genotype.The allelic frequency was C 76.9% and T 23.1%,respectively.The required warfarin dose for patients with the CYP4F2 rs2108622 genotype was CC(2.51±0.82) mg·d^-1,CT(2.74 ±0.96) mg·d^-1,and TT(3.20 ±1.22) mg·d^-1,respectively.Analysis of variance showed CYP4F2 rs2108622 was associated with warfarin dose.Conclusion:Our data shows that CYP4F2 rs2108622 is associated with the dose of warfarin in the Han population of the south of Jiangsu province.
出处 《药学与临床研究》 2010年第4期338-340,共3页 Pharmaceutical and Clinical Research
基金 江苏省卫生厅医药科技发展基金临床药学研究科技项目(P200804) 常州四药临床药学科研项目(CS2009901)
关键词 细胞色素P450酶4F2 华法林 基因多态性 CYP4F2 Warfarin Polymorphism
  • 相关文献

参考文献12

  • 1Borgiani P, Ci ccacci C, FORTE V, et al. Allelic variants in the CYP2C9 and VKORC1 loci and interindividual variability in the anticoagulant dose effect of warfarin in Italians [J]. Pharmacogenomics, 2007, 8 (11): 1545-50.
  • 2Caldwell MD, Awad T, Johnson JA, et al. CYP4F2 genetic variant ahers required warfarin dose [J]. Blood, 2008, 111(8): 4106-12.
  • 3LUO G, ZHENG L ZHANG X, et al. Genotyping of single nucleotide polymorphisms using base-quenched probe: a method does not invariably depend on the deoxyguanosine nucleotide[J].Anal Biochem, 2009, 386(2):. 161-6.
  • 4张俊,罗光华,郑璐,张晓膺,徐宁.单核苷酸多态性的碱基淬灭探针技术检测方法的建立[J].中华检验医学杂志,2009,32(9):1064-1068. 被引量:12
  • 5Li T, Chang CY, Jin DY, et al. Identification of the gene for vitamin K epoxide reductase [J]. Nature. 2004, 427, (6974): 541-4.
  • 6Borgiani P, Ciccacci C, Forte V, et al. CYP4F2 genetic variant (rs2108622) significantly contributes to warfarin dosing variability in the Italian population [J]. Pharmacogenomics, 2009, 10(2): 261-6.
  • 7Stec DE, Roman R J, Flasch A, et al. Polymorphism in human CYP4F2 decreases 20-HETE production [J]. Physiol Genomics, 2007, 30(1): 74-81.
  • 8McDonald MG, Rieder M J, Nakano M, et al. CYP4F2 is a vitamin K1 oxidase: An explanation for altered warfarin dose in carriers of the V433M variant [J]. Mol Pharmacol. 2009, 75(6): 1337-46.
  • 9The International HapMap Project[J]. Nature, 2003, 426 (6968): 789-96.
  • 10Rieder MJ, Reiner AP, Gage BF, et al. Effect of VKORCI haplotype on transeriptional regulati on and warfarin dose [J]. N Engl J Med, 2005, 352(22):2285-93.

二级参考文献10

  • 1罗光华,郑璐,张晓膺,许国锋,朱江,牟琴峰,魏江,陈陆俊,张俊,徐宁.ShineRoar探针技术检测单核苷酸多态性[J].中华检验医学杂志,2007,30(6):609-612. 被引量:8
  • 2Brookes AJ. The essence of SNPs. Gene, 1999,234 : 177-186.
  • 3The International HapMap Consortium. The international HapMap project. Nature, 2003,426:789-796.
  • 4Chung WH, Hung SI, Hong HS, et al. Medical genetics: a marker for Stevens-Johnson syndrome. Nature, 2004,428:486.
  • 5Carlson CS, Newman TL, Nickerson DA. SNPing in the human genome. Curr Opin Chem Biol, 2001,5:78-85.
  • 6Zhang R, Zhu Z, Zhu H, et al. SNP Cutter: a comprehensive tool for SNP PCR-RFLP assay design. Nucleic Acids Res, 2005, 33 : W489-492.
  • 7Takatsu K, Yokomaku T, Kurata S, et al. A new approach to SNP genotyping with fluorescently labeled mononucleotides. Nucleic Acids Res, 2004,32 : e60.
  • 8Crockett AO,Wittwer CT. Fluorescein-labeled oligonucleotides for real-time pcr: using the inherent quenching of deoxyguanosine nucleotides. Anal Biochem, 2001,290:89-97.
  • 9Vaughn CP, Elenitoba-Johnson KS. Hybridization-induced dequenching of fluorescein-labeled oligonucleotides: a novel strategy for PCR detection and genotyping. Am J Pathol, 2003, 163:29-35.
  • 10Kalinina O, Lebedeva I, Brown J, et al. Nanoliter scale PCR with TaqMan detection. Nucleic Acids Res, 1997,25 : 1999-2004.

共引文献11

同被引文献202

引证文献13

二级引证文献85

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部